These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 12235215)
1. Inhibition of type 1 cytokine-mediated inflammation by a soluble CD30 homologue encoded by ectromelia (mousepox) virus. Saraiva M; Smith P; Fallon PG; Alcami A J Exp Med; 2002 Sep; 196(6):829-39. PubMed ID: 12235215 [TBL] [Abstract][Full Text] [Related]
2. A method for the generation of ectromelia virus (ECTV) recombinants: in vivo analysis of ECTV vCD30 deletion mutants. Alejo A; Saraiva M; Ruiz-Argüello MB; Viejo-Borbolla A; de Marco MF; Salguero FJ; Alcami A PLoS One; 2009; 4(4):e5175. PubMed ID: 19365546 [TBL] [Abstract][Full Text] [Related]
3. Deficiency in Th2 cytokine responses exacerbate orthopoxvirus infection. Sakala IG; Chaudhri G; Eldi P; Buller RM; Karupiah G PLoS One; 2015; 10(3):e0118685. PubMed ID: 25751266 [TBL] [Abstract][Full Text] [Related]
4. Activation of HIV expression by CD30 triggering in CD4+ T cells from HIV-infected individuals. Maggi E; Annunziato F; Manetti R; Biagiotti R; Giudizi MG; Ravina A; Almerigogna F; Boiani N; Alderson M; Romagnani S Immunity; 1995 Aug; 3(2):251-5. PubMed ID: 7648397 [TBL] [Abstract][Full Text] [Related]
5. Co-expression of CD30 ligand and interleukin 4 (IL-4) receptors by acute myeloid leukaemia blasts is associated with the expansion of IL-4-producing CD30+ normal T cells. Rossi FM; Degan M; Mazzocco FT; Di Francia R; Aldinucci D; Poletto D; Vellenga E; Pinto A; Gattei V Br J Haematol; 2002 Apr; 117(1):59-69. PubMed ID: 11918534 [TBL] [Abstract][Full Text] [Related]
6. CD30-mediated signaling promotes the development of human T helper type 2-like T cells. Del Prete G; De Carli M; D'Elios MM; Daniel KC; Almerigogna F; Alderson M; Smith CA; Thomas E; Romagnani S J Exp Med; 1995 Dec; 182(6):1655-61. PubMed ID: 7500010 [TBL] [Abstract][Full Text] [Related]
7. CD30 ligand, a member of the TNF ligand superfamily, with growth and activation control CD30+ lymphoid and lymphoma cells. Gruss H-J ; Herrmann F Leuk Lymphoma; 1996 Feb; 20(5-6):397-409. PubMed ID: 8833395 [TBL] [Abstract][Full Text] [Related]
8. CD30 ligand (CD30L)-expressing acute myeloid leukemias: a new model of paracrine interactions for the regulation of blast cells proliferation. Gattei V; Degan M; Rossi FM; de Iuliis A; Mazzocco FT; Serraino D; Zagonel V; Aldinucci D; Pinto A Leuk Lymphoma; 1999 Sep; 35(1-2):21-35. PubMed ID: 10512160 [TBL] [Abstract][Full Text] [Related]
9. CD30 antigen: not a physiological marker for TH2 cells but an important costimulator molecule in the regulation of the balance between TH1/TH2 response. Pellegrini P; Berghella AM; Contasta I; Adorno D Transpl Immunol; 2003; 12(1):49-61. PubMed ID: 14551032 [TBL] [Abstract][Full Text] [Related]
10. Expression of mouse interleukin-4 by a recombinant ectromelia virus suppresses cytolytic lymphocyte responses and overcomes genetic resistance to mousepox. Jackson RJ; Ramsay AJ; Christensen CD; Beaton S; Hall DF; Ramshaw IA J Virol; 2001 Feb; 75(3):1205-10. PubMed ID: 11152493 [TBL] [Abstract][Full Text] [Related]
11. Polarized type 1 cytokine response and cell-mediated immunity determine genetic resistance to mousepox. Chaudhri G; Panchanathan V; Buller RM; van den Eertwegh AJ; Claassen E; Zhou J; de Chazal R; Laman JD; Karupiah G Proc Natl Acad Sci U S A; 2004 Jun; 101(24):9057-62. PubMed ID: 15184649 [TBL] [Abstract][Full Text] [Related]
12. CD30L up-regulates CD30 and IL-4 expression by T cells. Rossi FM; Degan M; Mazzocut-Zecchin L; Di Francia R; Aldinucci D; Pinto A; Gattei V FEBS Lett; 2001 Nov; 508(3):418-22. PubMed ID: 11728464 [TBL] [Abstract][Full Text] [Related]
13. Cowpox virus encodes a fifth member of the tumor necrosis factor receptor family: a soluble, secreted CD30 homologue. Panus JF; Smith CA; Ray CA; Smith TD; Patel DD; Pickup DJ Proc Natl Acad Sci U S A; 2002 Jun; 99(12):8348-53. PubMed ID: 12034885 [TBL] [Abstract][Full Text] [Related]
14. A critical role of CD30 ligand/CD30 in controlling inflammatory bowel diseases in mice. Sun X; Somada S; Shibata K; Muta H; Yamada H; Yoshihara H; Honda K; Nakamura K; Takayanagi R; Tani K; Podack ER; Yoshikai Y Gastroenterology; 2008 Feb; 134(2):447-58. PubMed ID: 18242212 [TBL] [Abstract][Full Text] [Related]
15. Expression and regulation of CD30 ligand and CD30 in human leukemia-lymphoma cell lines. Gruss HJ; DaSilva N; Hu ZB; Uphoff CC; Goodwin RG; Drexler HG Leukemia; 1994 Dec; 8(12):2083-94. PubMed ID: 7528856 [TBL] [Abstract][Full Text] [Related]
16. Expression of CD30 mRNA, CD30L mRNA and a variant form of CD30 mRNA in restimulated peripheral blood mononuclear cells (PBMC) of patients with helminthic infections resembling a Th2 disease. Kilwinski J; Berger T; Mpalaskas J; Reuter S; Flick W; Kern P Clin Exp Immunol; 1999 Jan; 115(1):114-9. PubMed ID: 9933429 [TBL] [Abstract][Full Text] [Related]
17. CD30 ligand/CD30 interaction is involved in pathogenesis of inflammatory bowel disease. Somada S; Muta H; Nakamura K; Sun X; Honda K; Ihara E; Akiho H; Takayanagi R; Yoshikai Y; Podack ER; Tani K Dig Dis Sci; 2012 Aug; 57(8):2031-7. PubMed ID: 22451116 [TBL] [Abstract][Full Text] [Related]
18. CD30 ligand/CD30 plays a critical role in Th17 differentiation in mice. Sun X; Yamada H; Shibata K; Muta H; Tani K; Podack ER; Yoshikai Y J Immunol; 2010 Aug; 185(4):2222-30. PubMed ID: 20639486 [TBL] [Abstract][Full Text] [Related]
19. Construction and expression of a soluble form of human CD30 ligand with functional activity. Powell IF; Li T; Jäck HM; Ellis TM J Leukoc Biol; 1998 Jun; 63(6):752-7. PubMed ID: 9620669 [TBL] [Abstract][Full Text] [Related]
20. Analysis of host response modifier ORFs of ectromelia virus, the causative agent of mousepox. Chen N; Buller RM; Wall EM; Upton C Virus Res; 2000 Feb; 66(2):155-73. PubMed ID: 10725549 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]